Status:
COMPLETED
Validation of Patient Reported Outcome Measures for Use in Hallux Valgus
Lead Sponsor:
Ipsen
Conditions:
Hallux Valgus
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to explore whether the mFFI is fit for purpose in adults with hallux valgus (HV).
Eligibility Criteria
Inclusion
- Male or female, of any race and, aged ≥ 18 years
- Clinical diagnosis of hallux valgus
- Fluent in reading/speaking US-English to read and understand informed consent form and to participate in the interview
Exclusion
- Participation in another foot-based clinical trial in the last 90 days or in Ipsen's clinical trial D-FR-52120-237
- Current chronic drug or alcohol abuse problem
Key Trial Info
Start Date :
October 30 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 15 2020
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03846687
Start Date
October 30 2018
End Date
January 15 2020
Last Update
January 27 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University Foot and Ankle Institute
Santa Monica, California, United States, 90403
2
Ankle and Foot Care Centers
Youngstown, Ohio, United States, 22801
3
Futuro Clinical Trials, LLC
McAllen, Texas, United States, 78501